In the broad healthcare landscape, one area that has historically been overlooked and under-prioritized is women's health.

Clerkenwell Health is proud to announce the launch of its foundation course for Psychedelic-Assisted Therapy, a comprehensive ...

Renée Aguiar-Lucander, CEO of Calliditas, is driving the advancement and launch of TARPEYO – the company’s medication ...

Interview: Is global AI regulation really revolutionizing pharma and clinical trials?

Owlstone Medical, a global leader in Breath Biopsy for early disease detection and precision medicine, has announced a ...

In the heart of Montreal sits the non-profit organization Centech, a place that supports projects and startups with high growth potential – from conception right through to commercialization, which it ...

Lonza, a global partner in the pharmaceutical, biotech, and nutraceutical sectors, announced the introduction of its ...

A significant milestone has been reached by Olden Labs as it steps into the limelight revealing its refreshing approach to ...

Response Pharmaceuticals, Inc., has unveiled significant findings from its Phase 1b clinical trial of RDX-002, signaling a ...

OSP spoke to Berkeley Research Group healthcare managing director, Wendy Cheng for a discussion around developments in AI ...

In an extensive and enlightening chat with Prasad Raje, the CEO of LGM Pharma, OSP gained profound insights into the company's trajectory within the pharmaceutical industry. LGM Pharma, under Raje's ...